Pages that link to "Q36363334"

The following pages link to Making unresectable hepatic colorectal metastases resectable--does it work? (Q36363334):

Displaying 13 items.

• Designing liver resections and pushing the envelope with resections for hepatic colorectal metastases (Q26864128) (← links)
• Iterative cytoreductive surgery associated with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis of colorectal origin with or without liver metastases (Q34003396) (← links)
• External validation of a pre-operative nomogram predicting peri-operative mortality risk after liver resections for malignancy. (Q35613928) (← links)
• Long-term results of radiofrequency ablation for unresectable colorectal liver metastases: a potentially curative intervention. (Q36324566) (← links)
• Recent trends in liver resection surgery activity and population utilization rates in English regions (Q36408408) (← links)
• Evolution of neoadjuvant therapy for extended hepatic metastases—have we reached our (non‐resectable) limit? (Q37821841) (← links)
• Chinese guidelines for the diagnosis and comprehensive treatment of hepatic metastasis of colorectal cancer (Q37907117) (← links)
• Chemotherapy-associated liver injury in patients with colorectal liver metastases: a systematic review and meta-analysis (Q38024277) (← links)
• Interleukin-6 is required for cell cycle arrest and activation of DNA repair enzymes after partial hepatectomy in mice (Q41951123) (← links)
• Assessment of liver metastases from colorectal adenocarcinoma following chemotherapy: SPIO-MRI versus FDG-PET/CT. (Q43007035) (← links)
• FDG-PET improves management of patients with colorectal liver metastases allocated for local treatment: a consecutive prospective study (Q46926508) (← links)
• Interleukin-6 inhibits oxidative injury and necrosis after extreme liver resection (Q51795648) (← links)
• Pre-operative nomogram to predict risk of peri-operative mortality following liver resections for malignancy (Q84997043) (← links)